Clinical Prognosis and Progression of Myasthenia Gravis Patients

NCT04101578 · clinicaltrials.gov ↗

UNKNOWN

Status

2000

Enrollment

INDIV

Sponsor class

Conditions

Myasthenia Gravis

Interventions

DRUG: Symptomatic Treatment, Steroids, Immunosuppressive Agents, Plasma Exchange(PE), Intravenous Immunoglobulin(IVIg)

Sponsor

Da, Yuwei, M.D.